Markku Kallajoki

- Docent,
Faculty of Medicine (University of Turku)

markku.kallajoki@utu.fi

Kiinamyllynkatu 10

Turku

4 of 4

Ewing's sarcoma family of tumors in Finland during 1990-2009 – A population-based study (2013)
- Acta Oncologica
Serlo JA, Helenius IJ, Sampo M, Vettenranta K, Saarinen-Pihkala UM, Kivivuori S, Riikonen P, Kivioja A, Bohling T, Kallajoki M, Ristimaki A, Vasama K, Tarkkanen M
Unusual Case of Inflammatory Myofibroblastic Tumor in Maxilla (2013)
- Case Reports in Dentistry
Jaana Rautava, Tero Soukka, Esko Peltonen, Petri Nurmenniemi, Markku Kallajoki, Stina Syrjänen
CIP2A Promotes Proliferation of Spermatogonial Progenitor Cells and Spermatogenesis in Mice (2012)
- PLoS ONE
Ventela S, Come C, Makela JA, Hobbs RM, Mannermaa L, Kallajoki M, Chan EK, Pandolfi PP, Toppari J, Westermarck J
c-Jun N-Terminal Kinase Phosphorylation of MARCKSL1 Determines Actin Stability and Migration in Neurons and in Cancer Cells (2012)
- Molecular and Cellular Biology
Bjorkblom B, Padzik A, Mohammad H, Westerlund N, Komulainen E, Hollos P, Parviainen L, Papageorgiou AC, Iljin K, Kallioniemi O, Kallajoki M, Courtney MJ, Magard M, James P, Coffey ET
Melanoma-Associated Cancer-Testis Antigen 16 (CT16) Regulates the Expression of Apoptotic and Antiapoptotic Genes and Promotes Cell Survival (2012)
- PLoS ONE
Nylund C, Rappu P, Pakula E, Heino A, Laato L, Elo LL, Vihinen P, Pyrhonen S, Owen GR, Larjava H, Kallajoki M, Heino J
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay (2011)
- International Journal of Cancer
Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Mirtti T, Alanen K, Kallajoki M, Vuoristo MS, Pyrhonen S, Heino J
PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities (2011)
- Nuclear Medicine and Biology
Paula Lindholm, Eija Sutinen, Vesa Oikonen, Kimmo Mattila, Maija Tarkkanen, Markku Kallajoki, Hannu Aro, Tom Böhling, Aarne Kivioja, Inkeri Elomaa, Heikki Minn
SerpinA1: A novel biomarker for progression of cutaneous squamous cell carcinoma (2011)
- Journal of Investigative Dermatology
Farshchian M, Kivisaari A, Ala-aho R, Riihila P, Kallajoki M, Grenman R, Peltonen J, Pihlajaniemi T, Heljasvaara K, Kahari V
Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma (2011)
- American Journal of Pathology
Farshchian M, Kivisaari A, Ala-Aho R, Riihilä P, Kallajoki M, Grénman R, Peltonen J, Pihlajaniemi T, Heljasvaara R, Kähäri VM
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay (2010)
- Journal of Investigative Dermatology
Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Alanen K, Kallajoki M, Pyrhönen S, Heino J
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma (2010)
- British Journal of Dermatology
Kivisaari A, Kallajoki M, Ala-aho R, McGrath J, Bauer J, Königova R, Medvecz M, Beckert W, Grenman R, Kähäri V-M
Silencing of Nuclear Mitotic Apparatus protein (NuMA) accelerates the apoptotic disintegration of the nucleus (2010)
- Apoptosis
Kivinen K, Taimen P, Kallajoki M
Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. (2009)
- Journal of Clinical Endocrinology and Metabolism
Nurmio M, Keros V, Lähteenmäki P, Salmi T, Kallajoki M, Jahnukainen K.
p38 alpha and p38 delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells (2007)
- Oncogene
Junttila MR, Ala-Aho R, Jokilehto T, Peltonen J, Kallajoki M, Grenman R, Jaakkola P, Westermarck J, Kahari VM